Evidence map›Paper›PMID 27571429›Full record

ArticleAnalytical chemistry2016

Combining Yeast Display and Competitive FACS to Select Rare Hapten-Specific Clones from Recombinant Antibody Libraries.

Yue Sun, Bhupal Ban, Andrew Bradbury, G A Shakeel Ansari, Diane A Blake

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Multiobjective VScience advances · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yue SunDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine , New Orleans, Louisiana, United States.
Bhupal BanDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine , New Orleans, Louisiana, United States.
Andrew BradburyBioscience Division, Los Alamos National Laboratory , Los Alamos, New Mexico, United States.
G A Shakeel AnsariDepartment of Pathology, University of Texas Medical Branch , Galveston, Texas, United States.
Diane A BlakeDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine , New Orleans, Louisiana, United States.
Tulane University · USLos Alamos National Laboratory · USThe University of Texas Medical Branch at Galveston · US

Funding

Synthetic Organic Chemistry CoreP30ES006676 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 1995 to 2017
$21.7M
Transdisciplinary Research Consortium for Gulf Resilience on Women's HealthU19ES020677 · NIEHS · TULANE UNIVERSITY OF LOUISIANA · PI LICHTVELD, MAUREEN Y. · 2011 to 2015
$7.1M
Mentoring a Cancer Genetics ProgramP20GM103518 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI DEININGER, PRESCOTT L. · 2012 to 2013
$4.3M
NIEHS NIH HHS P30 ES006676NIEHS NIH HHS U19 ES020677NIGMS NIH HHS P20 GM103518
6 · The paper itself

Abstract

The development of antibodies to low molecular weight haptens remains challenging due to both the low immunogenicity of many haptens and the cross-reactivity of the protein carriers used to generate the immune response. Recombinant antibodies and novel display technologies have greatly advanced antibody development; however, new techniques are still required to select rare hapten-specific antibodies from large recombinant libraries. In the present study, we used a combination of phage and yeast display to screen an immune antibody library (size, 4.4 × 10(6)) against hapten markers for petroleum contamination (phenanthrene and methylphenanthrenes). Selection via phage display was used first to enrich the library between 20- and 100-fold for clones that bound to phenanthrene-protein conjugates. The enriched libraries were subsequently transferred to a yeast display system and a newly developed competitive FACS procedure was employed to select rare hapten-specific clones. Competitive FACS increased the frequency of hapten-specific scFvs in our yeast-displayed scFvs from 0.025 to 0.005% in the original library to between 13 and 35% in selected pools. The presence of hapten-specific scFvs was confirmed by competitive ELISA using periplasmic protein. Three distinct antibody clones that recognize phenanthrene and methylphenanthrenes were selected, and their distinctive binding properties were characterized. To our knowledge, these are first antibodies that can distinguish between methylated (petrogenic) versus unmethylated (pyrogenic) phenanthrenes; such antibodies will be useful in detecting the sources of environmental contamination. This selection method could be generally adopted in the selection of other hapten-specific recombinant antibodies.

Indexed as

AnimalsAntibodies, MonoclonalAntibody AffinityAntibody SpecificityEnzyme-Linked Immunosorbent AssayHaptensMicePeptide LibraryPhenanthrenesRecombinant ProteinsSingle-Chain AntibodiesTwo-Hybrid System Techniques1-methylphenanthreneAntibodies, MonoclonalHaptensPeptide LibraryPhenanthrenesRecombinant ProteinsSingle-Chain Antibodies

Identifiers

PMID27571429
PMCPMC5032104
OpenAlexW2509198975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.